Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium Glycoside for Crohn's Disease Induction Remission
NCT02044952Phase 3Unknown
- Sponsor
- Weiming Biopharma
- Start
- Jan 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tripterygium wilfordii polyglycosides in Crohn's disease, sponsored by Weiming Biopharma. Status: unknown.
02
Drugs
tripterygium wilfordii polyglycosides
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02044952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044952.